Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.610
-0.050 (-3.01%)
At close: Feb 21, 2025, 4:00 PM
1.650
+0.040 (2.48%)
After-hours: Feb 21, 2025, 7:57 PM EST
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $113.84 million as of February 21, 2025. Its market cap has decreased by -17.58% in one year.
Market Cap
113.84M
Enterprise Value
-149.94M
1-Year Change
-17.58%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $113.84M, a decrease of -85.46%. That is a compound annual growth rate of -43.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 113.84M | -26.48% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |